http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2015224068-A1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_604a4da0d04fcf667e2b9ceab58130f2 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-132 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-00 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-132 |
filingDate | 2013-08-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_23c9508e3dbdb10b00d28920e38720d9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1b87df29b4e1fb0d5ce33bde7f254280 |
publicationDate | 2015-08-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | US-2015224068-A1 |
titleOfInvention | Putrescine and method to reduce risk of aneuploid pregnancy |
abstract | A medicament for reducing the risk of having an aneuploid pregnancy in a woman with reduced ovarian ornithine decarboxylase (ODC) activity level, the medicament includes putrescine. A use of putrescine for reducing the risk of having an aneuploid pregnancy in a woman with reduced ovarian ODC activity levels. A method for reducing the risk of having an aneuploid pregnancy in a woman with reduced ovarian ODC activity levels by administering putrescine. |
priorityDate | 2012-08-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 143.